Understand the source comparison
Systemic versus topical approach
Unlike KPV and GHK-Cu, which are primarily studied as topical applications for skin conditions, TB-500 works systemically. This is actually advantageous for widespread eczema, where applying topical treatments to large body surface areas is impractical and com
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Unlike KPV and GHK-Cu, which are primarily studied as topical applications for skin conditions, TB-500 works systemically. This is actually advantageous for widespread eczema, where applying topical treatments to large body surface areas is impractical and compliance-limited. A systemic peptide that promotes healing throughout the body can address eczema across all affected areas simultaneously.
- For researchers considering BPC-157 versus TB-500, the two peptides work through complementary mechanisms. BPC-157 acts primarily at the local tissue level, stimulating repair through VEGF and collagen pathways. TB-500 works systemically through actin binding and stem cell mobilization. Together, they address different aspects of the healing process. The Wolverine stack concept combining these healing peptides has gained attention in the research community for precisely this reason.